<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xia L</submitter><funding>Natural Science Foundation of Anhui Province</funding><pagination>104007</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12907901</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>91</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Multiple myeloma (MM) is an incurable plasma cell malignancy with high relapse rate. Recent studies have implicated dysregulated autophagy and ferroptosis in MM progression; however, the molecular links remain elusive. This study investigated the role of SDE2, a ubiquitin-like protein overexpressed in MM, in modulating autophagy-ferroptosis crosstalk via ATG5 degradation with the aim of identifying novel therapeutic targets.&lt;h4>Methods&lt;/h4>Using bioinformatic analysis of TCGA data, we identified SDE2 as a prognostic marker in MM. Functional validation included Western blot, co-immunoprecipitation, and ubiquitination assays in MM cell lines (H929, RPMI8226, OPM-2, and KMS-11) and patient-derived samples. Transwell migration, soft agar colony formation, and flow cytometry </pubmed_abstract><journal>Redox biology</journal><pubmed_title>Inhibition of SDE2 promotes autophagy-dependent ferroptosis in multiple myeloma.</pubmed_title><pmcid>PMC12907901</pmcid><funding_grant_id>2023AH053319</funding_grant_id><pubmed_authors>Zheng Y</pubmed_authors><pubmed_authors>Xia L</pubmed_authors><pubmed_authors>Bao J</pubmed_authors><pubmed_authors>Chen XW</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Zhao YC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of SDE2 promotes autophagy-dependent ferroptosis in multiple myeloma.</name><description>&lt;h4>Background&lt;/h4>Multiple myeloma (MM) is an incurable plasma cell malignancy with high relapse rate. Recent studies have implicated dysregulated autophagy and ferroptosis in MM progression; however, the molecular links remain elusive. This study investigated the role of SDE2, a ubiquitin-like protein overexpressed in MM, in modulating autophagy-ferroptosis crosstalk via ATG5 degradation with the aim of identifying novel therapeutic targets.&lt;h4>Methods&lt;/h4>Using bioinformatic analysis of TCGA data, we identified SDE2 as a prognostic marker in MM. Functional validation included Western blot, co-immunoprecipitation, and ubiquitination assays in MM cell lines (H929, RPMI8226, OPM-2, and KMS-11) and patient-derived samples. Transwell migration, soft agar colony formation, and flow cytometry </description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-16T05:11:53.353Z</modification><creation>2026-07-09T10:36:46.293Z</creation></dates><accession>S-EPMC12907901</accession><cross_references><pubmed>41666676</pubmed><doi>10.1016/j.redox.2026.104007</doi></cross_references></HashMap>